Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Etanercept and Rituximab in CLL/SLL
NCT00201682Phase 2Completed
- Start
- Oct 2002
- Primary completion
- Aug 2006
- Modality
- Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 2 trial of etanercept in chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL). Started Oct 2002; status: completed.
02
Drugs
etanercept
03
Conditions
chronic lymphocytic leukemia (CLL)small lymphocytic lymphoma (SLL)
Beyond the preview
Go deeper on NCT00201682.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00201682.